| BRXIX | VTIAX | BRXIX / VTIAX | |
| Total Expense Ratio | 0.52 | 0.09 | 578% |
| Annual Report Gross Expense Ratio | 0.52 | 0.09 | 578% |
| Fund Existence | 10 years | 15 years | - |
| Gain YTD | 34.443 | 28.912 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 558B | 0% |
| Annual Yield % from dividends | 2.48 | 2.69 | 92% |
| Returns for 1 year | 33.72 | 27.98 | 120% |
| Returns for 3 years | 69.03 | 49.10 | 141% |
| Returns for 5 years | 57.95 | 32.57 | 178% |
| Returns for 10 years | 107.91 | 78.16 | 138% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CIPTX | 12.10 | 0.04 | +0.33% |
| Champlain Strategic Focus Institutional | |||
| SVOAX | 13.32 | N/A | N/A |
| SEI US Managed Volatility F (SIMT) | |||
| SCPIX | 54.76 | -0.02 | -0.04% |
| DWS S&P 500 Index S | |||
| JFNNX | 81.42 | -0.20 | -0.25% |
| Janus Henderson Global Life Sciences N | |||
| VSFCX | 22.40 | -0.06 | -0.27% |
| Federated Hermes MDT Small Cap Value C | |||